Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone is skeptical and somewhat dismissive, exemplified by comments like 'I fingered IL-6 without reading,' showing minimal engagement with the scientific content. Meanwhile, mentions of FDA accelerating testing indicate some awareness of the potential clinical relevance, but a lack of detailed discussion reflects moderate interest and limited deep engagement.
Most discussions seem skeptical or dismissive, with comments like 'I fingered IL-6 without reading' indicating disagreement or disinterest.
There is a moderate level of interest, as some posts mention ongoing research and potential testing, but overall engagement is limited.
Posts do not deeply analyze the methodology or implications; they mainly reference the publication or make brief remarks.
The discussions suggest some recognition of importance, especially regarding FDA actions, but overall impact is viewed as preliminary or superficial.
Interleukin-6 as a Potential Biomarker of COVID-19 Progression @SSRN https://t.co/kjSjk0OB4m
I fingered IL-6 wihtout reading any of these papers about how covid-19 disease progression works. https://t.co/QoFEbUNi9U https://t.co/QjEVQ1dbIS https://t.co/3mj1tem7J3 FDA is putting a rush on IL-6 testing https://t.co/THfolzqfuU
Trend up+242: *Ulhaq ZS* et al (Med Mal Infect) __Interleukin-6 as a potential biomarker of COVID-19 progression__ https://t.co/fIzfFJOeN5
Interleukin-6 as a potential biomarker of COVID-19 progression https://t.co/dm8GohrCzs
In this video, we delve into the effects of spike proteins on the human body. Additionally, we discuss ivermectin's potential binding to the SARS-CoV-2 spike protein, highlighting current clinical trials aimed at…
The neurology expert discusses brain and nerve responses during COVID-19, focusing on using electrical stimulation of the vagus nerve to treat cytokine storms associated with the virus and potential therapeutic…
I fingered IL-6 wihtout reading any of these papers about how covid-19 disease progression works. https://t.co/QoFEbUNi9U https://t.co/QjEVQ1dbIS https://t.co/3mj1tem7J3 FDA is putting a rush on IL-6 testing https://t.co/THfolzqfuU
Interleukin-6 as a potential biomarker of COVID-19 progression https://t.co/dm8GohrCzs
Trend up+242: *Ulhaq ZS* et al (Med Mal Infect) __Interleukin-6 as a potential biomarker of COVID-19 progression__ https://t.co/fIzfFJOeN5
Interleukin-6 as a Potential Biomarker of COVID-19 Progression @SSRN https://t.co/kjSjk0OB4m
medmal.2020.03.007 18. Deng X, Lui B, Li J, Zhang J, Zhao Y, Xu K, et al ... https://doi.org/10.1016/j.jinf.2020.04.002 jmv.26031. 73. Rev Assoc Med Bras ...
... medmal.2020.05.001 and ... https://doi.org/10.1016/j.jcv. monia. Kidney Int. 2020;97:1083‐1088. https://doi.org/10.1016/j. 2020.104444 kint.2020.04.002 33.
LID - 10.1016/j.jfo.2020.04.002 [doi] AB - We report here the case of a 27 ... following these steps, professional liability risk (medical malpractice) can
Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect 2020;50:382–3. doi:10.1016/j.medmal.2020.04.002. [124] Tocilizumab improves ...
2020.04.002. of this drug is excellent. Further multicenter and ... doi: 10.1016/j. All authors declare no competing interests. jcv.2020.104380 ...
... J. Appl. Physiol. 1962;17:689–692. National Academies of Sciences ... 10.1016/j.cclet.2020.04.002 Wearable near‐field communication ...
https://doi.org/10.1016/j.jinf.2020.04.002. Lobo, V., Patil, A ... https://doi.org/10.1016/j.medmal.2020.03.007. 61. Wen, Z., Wang, Q ...
みW
U
TL
GS